55
Participants
Start Date
September 15, 2020
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2030
Intraperitoneal chemotherapy during surgery
During interval surgery the patient will undergo HIPEC (Cisplatin 100mg/m2, 1h 30 infusions with sodium thiosulfate renal protection). They will then receive postoperative IPC i.e intravenous and intraperitoneal administration (IV Paclitaxel, 135mg/m2 on D1, IP Carboplatin, AUC 6 on D1, and IP Paclitaxel, 60mg/m2 on D8) with at least 3 courses performed (up to 4-6 allowed).
RECRUITING
Institut du Cancer de Montpellier - Val d'Aurelle, Montpellier
Direction Générale de l'Offre de Soins
OTHER_GOV
Institut du Cancer de Montpellier - Val d'Aurelle
OTHER